Log in or Sign up for Free to view tailored content for your specialty!
Irritable Bowel Syndrome News
Peter Gibson, MD: Nutrition, Innovation and Entrepreneurship
In this episode, Peter Gibson, MD, discusses the advent of FODMAPs, the importance of integrated care and preventive medicine, and how his research led to the development of a widely popular medical app.
RHB-102 improves stool consistency in patients with IBS-D
In men and women with diarrhea-predominant irritable bowel syndrome, RHB-102 was an effective and safe treatment, according to the American Journal of Gastroenterology.
Log in or Sign up for Free to view tailored content for your specialty!
Celiac linked with increased IBS, functional constipation risk
Children with celiac disease have a higher risk for irritable bowel syndrome and functional constipation even if they adhere to a gluten-free diet, according to study results.
Investigational drug improves stool consistency in IBS-D
An investigational, bimodal release ondansetron tablet improved stool consistency in patients with diarrhea-predominant irritable bowel syndrome, according to study results.
Minesapride safe, well-tolerated in IBS-C
Minesapride, an agonist of 5-hydroxytryptamine 4 receptor, was safe and well-tolerated among patients with constipation-predominant irritable bowel syndrome, according to study results.
Antibiotics after colonoscopy linked with higher risk of subsequent IBS
Antibiotic exposure within 14 days after a screening colonoscopy correlated with an increased chance of subsequent irritable bowel syndrome, according to data from Digestive Disease Week.
VIDEO: Trulance improves pain in chronic idiopathic constipation, IBS-C
In this exclusive video, Gregory Sayuk, MD, MPH, from the division of gastroenterology at Washington University School of Medicine in St. Louis discusses his poster from Digestive Disease Week on four randomized trials that explored the efficacy of Trulance in patients with chronic idiopathic constipation and constipation-predominant irritable bowel syndrome.
VIDEO: Post-COVID ‘ideal practice’ will be mix of traditional, virtual care
In this exclusive video, Gregory S. Sayuk, MD, MPH, of the division of gastroenterology at Washington University School of Medicine in St. Louis, discusses how providers and patients have adapted to changes implemented in gastroenterology practices in response to the COVID-19 pandemic.
Several psychological therapies found to be efficacious for IBS
According to a systematic review and network analysis published in Gut, several psychological therapies were efficacious for treatment of irritable bowel syndrome; however, none were better compared with another.
‘Smart toilet’ could help detect cancer, other diseases
A device that can be mounted on an everyday toilet could be used to help detect multiple diseases, including certain cancers, chronic kidney disease and irritable bowel syndrome, according to research published in Nature Biomedical Engineering.
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read